Podiatrists in Loma Linda, CA Accepting Medicare

24 Podiatrists found. Showing 21 - 24

Dr. Michael Lynn Collins, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 11332 Mountain View Ave, Suite A, Loma Linda, CA 92354 Phone: 909-796-3707    Fax: 909-796-3707

Dr. Elnaz Hamedani, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 11201 Benton St, Loma Linda, CA 92357 Phone: 909-825-7084

Ali Ahmad Chaaban, DPM Podiatrist - Foot & Ankle Surgery Medicare: Not Enrolled in Medicare Practice Location: 11201 Benton St, Loma Linda, CA 92357 Phone: 909-825-7084

Rebecca M. Akolo, D.P.M Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 25279 Taylor St, Unit A, Loma Linda, CA 92354 Phone: 510-528-9609

News Archive

Novelos Therapeutics enters into a definitive agreement with Purdue Pharma to raise funds

Novelos Therapeutics, Inc. (OTCBB: NVLT), a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, today announced that Novelos entered into a definitive agreement with Purdue Pharma L.P., an existing investor, to sell 13,636,364 shares of its common stock and warrants, expiring on December 31, 2015, to purchase an aggregate of approximately 4,772,728 shares of common stock at an exercise price of $0.66 per share, for gross proceeds of $9 million.

ACM Global acquires Phoenix PCS to expand operation in the Asia Pacific region

ACM Global Central Laboratory, a diagnostic central laboratory specializing in delivering high quality testing services which optimize clinical trial outcomes, today announced it has acquired Phoenix Pharma Central Services Pte. Ltd, a premier central laboratory services provider for Asia Pacific clinical trials, with laboratory facilities in Singapore and Shanghai, China. The acquisition enables ACM Global to deliver increased operational and financial efficiencies to clients conducting clinical studies in the Asia Pacific region. Terms of the transaction were not disclosed.

Theragenics reports consolidated revenue of $20.3 million for first quarter 2011

Theragenics Corporation, a medical device company serving the surgical products and prostate cancer treatment markets, today announced consolidated financial results for the first quarter ended March 31, 2011.

Physical activity can reduce prevalence of metabolic syndrome, CVD risk factors

Metabolic syndrome (MetS) is made up of unhealthy cardiovascular disease (CVD) risk factors including abdominal obesity, high levels of triglycerides, low level of HDL-cholesterol, elevated blood pressure, and elevated fasting glucose level as defined by the American Heart Association/ National Heart, Lung, and Blood Institute (AHA/NHLBI).

Read more Medical News

› Verified 3 days ago

• 1
• 2(current)